The global hemostatic gels market is expected to grow from USD 1.13 billion in 2025 to USD 2.17 billion by 2035, reflecting a strong compound annual growth rate (CAGR) of 6.6% during the forecast period. This growth is driven by increasing surgical procedures, rising trauma cases, and the growing need for advanced blood management solutions in operating rooms and critical care.
Hemostatic gels are topical agents designed to rapidly control bleeding by enhancing the body's natural clotting mechanism. Their applications span general surgery, orthopedics, cardiovascular procedures, dental surgeries, and minimally invasive operations, where precise, quick hemostasis is essential. Unlike mechanical methods such as sutures or staples, gel-based hemostats offer improved usability, reduced operative time, and better performance in highly vascularized or irregular anatomical sites.
The global surgical landscape is evolving, with increasing volumes of cardiac, oncologic, liver, and spine surgeries that require effective hemostatic interventions. Simultaneously, the rise in robot-assisted and laparoscopic surgeries is amplifying demand for adaptable, biocompatible gel formulations that minimize tissue damage and support efficient procedural workflows.
North America currently leads the market due to advanced healthcare infrastructure, established reimbursement pathways, and early adoption of surgical innovations. Meanwhile, Asia Pacific is emerging as a lucrative growth region, propelled by healthcare system modernization, growing surgical volumes, and enhanced awareness around blood loss management and perioperative safety.
At a 2023 product unveiling, Todd Dewey, CEO of Arch Therapeutics, remarked: “With hospitals seeking safer, faster ways to manage bleeding in complex surgeries, our hemostatic gel technology is positioned to meet a critical clinical need.” His comments reflect the market’s innovation trajectory and commitment to safer surgical care.
With continued investment in bioengineered hemostatic solutions, rising global surgery rates, and growing trauma response systems, the hemostatic gels industry is poised for sustained and dynamic growth through 2035.
Key Industry Attributes
| Attribute | Detail |
|---|---|
| Industry Size (2025) | USD 1.13 billion |
| Industry Size (2035) | USD 2.17 billion |
| CAGR (2025 to 2035) | 6.6% |
Bovine-based gels lead the market with a 38.4% share, while general surgery dominates with 41.7%, driven by increased surgical procedures and the rising need for effective intraoperative bleeding control. Demand is also influenced by improved biocompatibility and ease of use in diverse clinical settings.
Bovine-based hemostatic gels are projected to lead the global market, accounting for 38.4% share in 2025. These gels are favored for their strong coagulative action, biocompatibility, and rapid absorption-making them highly effective in managing surgical bleeding across multiple specialties. Derived from bovine-derived collagen or gelatin, they interact with platelets and fibrin to form a stable clot quickly, reducing operative time and improving patient outcomes.
Their widespread use is attributed to ease of handling, low immunogenic response, and ability to conform to irregular wound surfaces. Bovine-based gels are approved for a broad range of procedures, including general, cardiovascular, orthopedic, and dental surgeries.
Leading manufacturers like Pfizer, Baxter International, and CryoLife have developed advanced bovine-based gel formulations that offer faster resorption, improved hemostasis time, and lower risk of infection. As minimally invasive and robotic-assisted surgeries rise globally, the adaptability and reliability of bovine-derived hemostatic agents will continue to make them the go-to material in operating rooms across hospitals, clinics, and ambulatory surgical centers.
General surgery is anticipated to dominate the hemostatic gels market by application, holding a 41.7% share in 2025. The high prevalence of abdominal, gastrointestinal, and trauma-related procedures drives demand for fast-acting and easy-to-apply hemostatic solutions. Hemostatic gels are increasingly used to manage intraoperative bleeding, particularly in soft tissue procedures where traditional suturing or cauterization is not ideal.
These gels improve surgical efficiency by reducing blood loss, minimizing the need for transfusions, and shortening recovery times. Their effectiveness in both open and laparoscopic surgeries enhances their value in general surgical settings. The shift toward enhanced recovery protocols and same-day discharge models also boosts the adoption of hemostatic gels that ensure immediate and reliable clotting.
Surgeons prefer gels for their precision, minimal residue, and ability to maintain hemostasis even in moist or mobile surgical fields. Companies like Ethicon, B. Braun, and Medtronic are introducing next-gen hemostatic gels tailored for general surgery with improved adhesive properties and antimicrobial enhancements. As surgical volumes continue to rise globally-particularly in aging populations-the demand for hemostatic agents in general surgery will remain robust.
Hemostasis has high clinical importance in preventive, surgical, and emergency circumstances as blood loss may cause substantial diseases and deaths in civil and military individuals owing to bleeding problems rising from surgery, trauma injuries, and as hereditary, disease-related, or drug-induced blood syndromes.
For externally accessible injuries, a range of natural and synthetic biomaterials have to go through strong research, leading to hemostatic technologies including bandages, dressings, fibrin glues, tourniquets, tamponades, and hemostatic powders.
In contrast, treatment of internal non-compressible hemorrhage still severely relies on transfusion of pure blood or blood hemostatic components such as platelets, coagulation factors, and fibrinogens. Transfusion of platelets may experience significant challenges of high cost, limited availability, contamination risks, short shelf-life, performance variability, low portability, and immunological adverse reactions.
The usage of these blood hemostatic components provides only partial mechanisms for hemostasis. Through such concerns, interdisciplinary research is being conducted for the development of hemostatic gels that can be manufactured conveniently, and administered intravenously to mimic, leverage, and amplify physiological hemostatic mechanisms. This is expected to create opportunities for growth in the market for the development of effective and efficient hemostats.
Increasing Incidence of Lifestyle Related Disorders is Driving Demand for Hemostatic Gels
The USA dominated the North America hemostatic gels market, accounting for 82% of the total markets share in 2024. Rising prevalence of cardiovascular disorders, diabetes, and cancer in the USA. is propelling the volume of surgical procedures, thereby necessitating hemostatic gels.
With the global rise in the incidence of chronic diseases, the volume of surgical procedures is expected to increase in the forthcoming years, which is expected to drive demand hemostatic gels for blood loss management.
According to the CDC, around 150 million Americans are suffering from at least one chronic condition, which leads to the need for surgery. With the growing incidence of chronic diseases, the number of injuries and surgeries is expected to increase, thereby increasing the usage of hemostatic gels in the USA
Rising Expenditure on Healthcare Infrastructure Will Augment Sales of Hemostatic Gels
Demand for hemostatic gels in India is set to increase at a 7.4% CAGR over the assessment period. The market in India is driven by increasing demand for hemostatic gels due to growing government initiatives to create awareness about the product.
For instance, in November 2023, the transport department of the Rajasthan government mandated the addition of feracrylum, a hemostatic gel, in the first aid of all vehicles that are being registered from November 2023 following a direction of the high court. Feracrylum has been recognized to be a hemostatic agent by several clinical studies.
Growing Trend of Medical Tourism in the UK Will Fuel the Adoption of Hemostatic Gels
Sales in the UK market are projected to increase at a 7.1% CAGR over the forecast period. As per the British heart foundation (UK) and its heart and circulatory disease statistics, in 2020, there has been a substantial surge in the number of cardiac surgeries such as aortic valve replacement and angioplasty in the UK
Hemostatic gels have higher application in cardiovascular surgeries due to better clinical outcomes compared to other wound closure techniques. Thus, a growing number of cardiac surgeries is expected to spur demand for effective hemostatic gels in the UK
Increaisng Establishment of Hospitals and Ambulatory Centers in China Will Propel Demand for Hemostatic Gels
China held approximately 38.0% of the East Asia hemostatic gels market in 2024. As per the report, sales are forecast to grow at a 8.0% CAGR through 2035.
The government in China is investing heavily in the construction of healthcare infrastructure such as hospitals and clinics. As per an article published in 2023, China announced an investment of USD 4.6 Billion for the construction of hospitals in Wuhan.
There are now about 26,000 hospitals in China, more than in any other country; among them 60% are public and 40% are in the private sector. The significant growth in the number of hospitals and surgical centers is expected to boost sales of hemostatic gels.
Leading players operating in the global hemostatic gels market are launching innovative products to meet the demand for a hemostatic gel that can be easily and specifically applied, particularly for irregular fractures where bandages can be difficult, and powders are messy and can cause uneasiness. For instance:
With several competitors in hemostatic gels manufacturing, the overall market is highly fragmented. To meet consumer demand and expand their customer base, these companies are implementing methods such as mergers and acquisitions, partnerships, and collaborations. For instance:
| Report Attributes | Details |
|---|---|
| Market Size (2025) | USD 1.13 billion |
| Projected Market Size (2035) | USD 2.17 billion |
| CAGR (2025 to 2035) | 6.6% |
| Base Year for Estimation | 2024 |
| Historical Period | 2020 to 2024 |
| Projections Period | 2025 to 2035 |
| Quantitative Units | USD billion for value and million units for volume |
| Materials Analyzed (Segment 1) | Bovine-Based, Porcine-Based, Polymer-Based |
| Indications Analyzed (Segment 2) | General Surgery, Dental Surgery, Veterinary Surgery, Cardiovascular Surgery, Orthopaedic Surgery, Others |
| End Users Analyzed (Segment 3) | Hospitals, Speciality Clinics, Veterinary Settings, Ambulatory Surgical Centers, Online Sales |
| Regions Covered | North America; Latin America; Europe; South Asia; East Asia; Oceania; Middle East and Africa |
| Countries Covered | United States, Canada, Brazil, Mexico, Germany, France, United Kingdom, Italy, China, Japan, South Korea, India, Australia, UAE, Saudi Arabia, South Africa |
| Key Players Influencing the Market | Baxter, Bio to Chem LLC, Clinician's Choice Dental Products Inc., Cresilon (VETIGEL), DSI Ltd., ENDOVISION CO., LTD, Ethicon USA LLC, F&A Medical, PrevestDenPro, Septodont, Teleflex Incorporated, Ultradent Products Inc., VladMiVa, Medcura Inc. |
| Additional Attributes | Manufacturers of hemostatic gels market would want to know dollar sales by material type, share by surgery category and end user, demand surge in dental and general surgery, price competitiveness, and usage trends in ambulatory vs. hospital settings. |
Table 01: Global Hemostatic Gels Market Value (US$ Mn) Analysis 2017–2021, By Material
Table 02: Global Hemostatic Gels Market Value (US$ Mn) Opportunity Assessment 2022–2032, By Material
Table 03: Global Hemostatic Gels Market Value (US$ Mn) Analysis 2017–2021, By Indication
Table 04: Global Hemostatic Gels Market Value (US$ Mn) Opportunity Assessment 2022–2032, By Indication
Table 05: Global Hemostatic Gels Market Value (US$ Mn) Analysis 2017–2021, By End User
Table 06: Global Hemostatic Gels Market Value (US$ Mn) Opportunity Assessment 2022–2032, By End User
Table 07: Global Hemostatic Gels Market Value (US$ Mn) Analysis 2017–2021, By Region
Table 08: Global Hemostatic Gels Market Value (US$ Mn) Opportunity Assessment 2022–2032, By Region
Table 09: North America Hemostatic Gels Market Value (US$ Mn) Analysis 2017–2021, By Country
Table 10: North America Hemostatic Gels Market Value (US$ Mn) Opportunity Assessment 2022–2032, By Country
Table 11: North America Hemostatic Gels Market Value (US$ Mn) Analysis 2017–2021, By Material
Table 12: North America Hemostatic Gels Market Value (US$ Mn) Opportunity Assessment 2022–2032, By Material
Table 13: North America Hemostatic Gels Market Value (US$ Mn) Analysis 2017–2021, By Indication
Table 14: North America Hemostatic Gels Market Value (US$ Mn) Opportunity Assessment 2022–2032, By Indication
Table 15: North America Hemostatic Gels Market Value (US$ Mn) Analysis 2017–2021, By End User
Table 16: North America Hemostatic Gels Market Value (US$ Mn) Opportunity Assessment 2022–2032, By End User
Table 17: Latin America Hemostatic Gels Market Value (US$ Mn) Analysis 2017–2021, By Country
Table 18: Latin America Hemostatic Gels Market Value (US$ Mn) Opportunity Assessment 2022–2032, By Country
Table 19: Latin America Hemostatic Gels Market Value (US$ Mn) Analysis 2017–2021, By Material
Table 20: Latin America Hemostatic Gels Market Value (US$ Mn) Opportunity Assessment 2022–2032, By Material
Table 21: Latin America Hemostatic Gels Market Value (US$ Mn) Analysis 2017–2021, By Indication
Table 22: Latin America Hemostatic Gels Market Value (US$ Mn) Opportunity Assessment 2022–2032, By Indication
Table 23: Latin America Hemostatic Gels Market Value (US$ Mn) Analysis 2017–2021, By End User
Table 24: Latin America Hemostatic Gels Market Value (US$ Mn) Opportunity Assessment 2022–2032, By End User
Table 25: Europe Hemostatic Gels Market Value (US$ Mn) Analysis 2017–2021, By Country
Table 26: Europe Hemostatic Gels Market Value (US$ Mn) Opportunity Assessment 2022–2032, By Country
Table 27: Europe Hemostatic Gels Market Value (US$ Mn) Analysis 2017–2021, By Material
Table 28: Europe Hemostatic Gels Market Value (US$ Mn) Opportunity Assessment 2022–2032, By Material
Table 29: Europe Hemostatic Gels Market Value (US$ Mn) Analysis 2017–2021, By Indication
Table 30: Europe Hemostatic Gels Market Value (US$ Mn) Opportunity Assessment 2022–2032, By Indication
Table 31: Europe Hemostatic Gels Market Value (US$ Mn) Analysis 2017–2021, By End User
Table 32: Europe Hemostatic Gels Market Value (US$ Mn) Opportunity Assessment 2022–2032, By End User
Table 33: South Asia Hemostatic Gels Market Value (US$ Mn) Analysis 2017–2021, By Country
Table 34: South Asia Hemostatic Gels Market Value (US$ Mn) Opportunity Assessment 2022–2032, By Country
Table 35: South Asia Hemostatic Gels Market Value (US$ Mn) Analysis 2017–2021, By Material
Table 36: South Asia Hemostatic Gels Market Value (US$ Mn) Opportunity Assessment 2022–2032, By Material
Table 37: South Asia Hemostatic Gels Market Value (US$ Mn) Analysis 2017–2021, By Indication
Table 38: South Asia Hemostatic Gels Market Value (US$ Mn) Opportunity Assessment 2022–2032, By Indication
Table 39: South Asia Hemostatic Gels Market Value (US$ Mn) Analysis 2017–2021, By End User
Table 40: South Asia Hemostatic Gels Market Value (US$ Mn) Opportunity Assessment 2022–2032, By End User
Table 41: East Asia Hemostatic Gels Market Value (US$ Mn) Analysis 2017–2021, By Country
Table 42: East Asia Hemostatic Gels Market Value (US$ Mn) Opportunity Assessment 2022–2032, By Country
Table 43: East Asia Hemostatic Gels Market Value (US$ Mn) Analysis 2017–2021, By Material
Table 44: East Asia Hemostatic Gels Market Value (US$ Mn) Opportunity Assessment 2022–2032, By Material
Table 45: East Asia Hemostatic Gels Market Value (US$ Mn) Analysis 2017–2021, By Indication
Table 46: East Asia Hemostatic Gels Market Value (US$ Mn) Opportunity Assessment 2022–2032, By Indication
Table 47: East Asia Hemostatic Gels Market Value (US$ Mn) Analysis 2017–2021, By End User
Table 48: East Asia Hemostatic Gels Market Value (US$ Mn) Opportunity Assessment 2022–2032, By End User
Table 49: Oceania Hemostatic Gels Market Value (US$ Mn) Analysis 2017–2021, By Country
Table 50: Oceania Hemostatic Gels Market Value (US$ Mn) Opportunity Assessment 2022–2032, By Country
Table 51: Oceania Hemostatic Gels Market Value (US$ Mn) Analysis 2017–2021, By Material
Table 52: Oceania Hemostatic Gels Market Value (US$ Mn) Opportunity Assessment 2022–2032, By Material
Table 53: Oceania Hemostatic Gels Market Value (US$ Mn) Analysis 2017–2021, By Indication
Table 54: Oceania Hemostatic Gels Market Value (US$ Mn) Opportunity Assessment 2022–2032, By Indication
Table 55: Oceania Hemostatic Gels Market Value (US$ Mn) Analysis 2017–2021, By End User
Table 56: Oceania Hemostatic Gels Market Value (US$ Mn) Opportunity Assessment 2022–2032, By End User
Table 57: Middle East and Africa Hemostatic Gels Market Value (US$ Mn) Analysis 2017–2021, By Country
Table 58: Middle East and Africa Hemostatic Gels Market Value (US$ Mn) Opportunity Assessment 2022–2032, By Country
Table 59: Middle East and Africa (MEA) Hemostatic Gels Market Value (US$ Mn) Analysis 2017–2021, By Material
Table 60: Middle East and Africa (MEA) Hemostatic Gels Market Value (US$ Mn) Opportunity Assessment 2022–2032, By Material
Table 61: Middle East and Africa (MEA) Hemostatic Gels Market Value (US$ Mn) Analysis 2017–2021, By Indication
Table 62: Middle East and Africa (MEA) Hemostatic Gels Market Value (US$ Mn) Opportunity Assessment 2022–2032, By Indication
Table 63: Middle East and Africa (MEA) Hemostatic Gels Market Value (US$ Mn) Analysis 2017–2021, By End User
Table 64: Middle East and Africa (MEA) Hemostatic Gels Market Value (US$ Mn) Opportunity Assessment 2022–2032, By End User
Figure 01: Global Hemostatic Gels Market Historical Market Value (US$ Mn) Analysis, 2017–2021
Figure 02: Global Hemostatic Gels Market Value (US$ Mn), 2022 – 2032 & Y-o-Y Growth Trend Analysis
Figure 03: Global Hemostatic Gels Market Absolute $ Opportunity, 2022-2032
Figure 04: Global Hemostatic Gels Market Share Analysis (%), By Material, 2021 & 2032
Figure 05: Global Hemostatic Gels Market Y-o-Y Analysis (%), By Material, 2022-2032
Figure 06: Global Hemostatic Gels Market Attractiveness Analysis By Material, 2022-2032
Figure 07: Global Hemostatic Gels Market Share Analysis (%), By Indication, 2021 & 2032
Figure 08: Global Hemostatic Gels Market Y-o-Y Analysis (%), By Indication, 2022-2032
Figure 09: Global Hemostatic Gels Market Attractiveness Analysis By Indication, 2022-2032
Figure 10: Global Hemostatic Gels Market Share Analysis (%), By End User, 2021 & 2032
Figure 11: Global Hemostatic Gels Market Y-o-Y Analysis (%), By End User, 2022-2032
Figure 12: Global Hemostatic Gels Market Attractiveness Analysis by End User, 2022-2032
Figure 13: Global Hemostatic Gels Market Share Analysis (%), By Region, 2021 & 2032
Figure 14: Global Hemostatic Gels Market Y-o-Y Analysis (%), By Region, 2022-2032
Figure 15: Global Hemostatic Gels Market Attractiveness Analysis by Region, 2022-2032
Figure 16: North America Hemostatic Gels Market Share Analysis (%), By Country (2022)
Figure 17: North America Hemostatic Gels Market Share Analysis (%), By Material (2022)
Figure 18: North America Hemostatic Gels Market Share Analysis (%), By Indication (2022)
Figure 19: North America Hemostatic Gels Market Share Analysis (%), By End User (2022)
Figure 20: North America Hemostatic Gels Market Value (US$ Mn) Analysis, 2017–2021
Figure 21: North America Hemostatic Gels Market Current and Future Market Value (US$ Mn), 2022-2032 & Y-o-Y Growth Trend Analysis
Figure 22: North America Hemostatic Gels Market Attractiveness Analysis, By Country
Figure 23: North America Hemostatic Gels Market Attractiveness Analysis, By Material
Figure 24: North America Hemostatic Gels Market Attractiveness Analysis, By Indication
Figure 25: North America Hemostatic Gels Market Attractiveness Analysis, By End User
Figure 26: U.S. Market Value Proportion Analysis, 2021
Figure 27: Global Vs U.S. Y-o-Y Growth Comparison, 2021-2032
Figure 28: U.S. Hemostatic Gels Market Share Analysis (%), By Material, 2021 & 2032
Figure 29: U.S. Hemostatic Gels Market Share Analysis (%), By Indication, 2021 & 2032
Figure 30: U.S. Hemostatic Gels Market Share Analysis (%), By End User, 2021 & 2032
Figure 31: Canada Market Value Proportion Analysis, 2021
Figure 32: Global Vs Canada Y-o-Y Growth Comparison, 2021-2032
Figure 33: Canada Hemostatic Gels Market Share Analysis (%), By Material, 2021 & 2032
Figure 34: Canada Hemostatic Gels Market Share Analysis (%), By Indication, 2021 & 2032
Figure 35: Canada Hemostatic Gels Market Share Analysis (%), By End User, 2021 & 2032
Figure 36: Latin America Hemostatic Gels Market Share Analysis (%), By Country (2022)
Figure 37: Latin America Hemostatic Gels Market Share Analysis (%), By Material (2022)
Figure 38: Latin America Hemostatic Gels Market Share Analysis (%), By Indication (2022)
Figure 39: Latin America Hemostatic Gels Market Share Analysis (%), By End User (2022)
Figure 40: Latin America Hemostatic Gels Market Historical Market Value (US$ Mn) Analysis, 2017–2021
Figure 41: Latin America Hemostatic Gels Market Current and Future Market Value (US$ Mn), 2022-2032 & Y-o-Y Growth Trend Analysis
Figure 42: Latin America Hemostatic Gels Market Attractiveness Analysis, By Country
Figure 43: Latin America Hemostatic Gels Market Attractiveness Analysis, By Material
Figure 44: Latin America Hemostatic Gels Market Market Attractiveness Analysis, By Indication
Figure 45: Latin America Hemostatic Gels Market Attractiveness Analysis, By End User
Figure 46: Brazil Market Value Proportion Analysis, 2021
Figure 47: Global Vs Brazil Y-o-Y Growth Comparison, 2021-2032
Figure 48: Brazil Hemostatic Gels Market Share Analysis (%), By Material, 2021 & 2032
Figure 49: Brazil Hemostatic Gels Market Share Analysis (%), By Indication, 2021 & 2032
Figure 50: Brazil Hemostatic Gels Market Share Analysis (%), By End User, 2021 & 2032
Figure 51: Mexico Market Value Proportion Analysis, 2021
Figure 52: Global Vs Mexico Y-o-Y Growth Comparison, 2021-2032
Figure 53: Mexico Hemostatic Gels Market Share Analysis (%), By Material, 2021 & 2032
Figure 54: Mexico Hemostatic Gels Market Share Analysis (%), By Indication, 2021 & 2032
Figure 55: Mexico Hemostatic Gels Market Share Analysis (%), By End User, 2021 & 2032
Figure 56: Argentina Market Value Proportion Analysis, 2021
Figure 57: Global Vs Argentina Y-o-Y Growth Comparison, 2021-2032
Figure 58: Argentina Hemostatic Gels Market Share Analysis (%), By Material, 2021 & 2032
Figure 59: Argentina Hemostatic Gels Market Share Analysis (%), By Indication, 2021 & 2032
Figure 60: Argentina Hemostatic Gels Market Share Analysis (%), By End User, 2021 & 2032
Figure 61: Europe Hemostatic Gels Market Share Analysis (%), By Country (2022)
Figure 62: Europe Hemostatic Gels Market Share Analysis (%), By Material (2022)
Figure 63: Europe Hemostatic Gels Market Share Analysis (%), By Indication (2022)
Figure 64: Europe Hemostatic Gels Market Share Analysis (%), By End User (2022)
Figure 65: Europe Hemostatic Gels Market Historical Market Value (US$ Mn) Analysis, 2017–2021
Figure 66: Europe Hemostatic Gels Market Current and Future Market Value (US$ Mn), 2022-2032 & Y-o-Y Growth Trend Analysis
Figure 67: Europe Hemostatic Gels Market Market Attractiveness Analysis, By Country
Figure 68: Europe Hemostatic Gels Market Attractiveness Analysis, By Material
Figure 69: Europe Hemostatic Gels Market Market Attractiveness Analysis, By Indication
Figure 70: Europe Hemostatic Gels Market Attractiveness Analysis, By End User
Figure 71: Germany Market Value Proportion Analysis, 2021
Figure 72: Global Vs Germany Y-o-Y Growth Comparison, 2021-2032
Figure 73: Germany Hemostatic Gels Market Share Analysis (%), By Material, 2021 & 2032
Figure 74: Germany Hemostatic Gels Market Share Analysis (%), By Indication, 2021 & 2032
Figure 75: Germany Hemostatic Gels Market Share Analysis (%), By End User, 2021 & 2032
Figure 76: Italy Market Value Proportion Analysis, 2021
Figure 77: Global Vs Italy Y-o-Y Growth Comparison, 2021-2032
Figure 78: Italy Hemostatic Gels Market Share Analysis (%), By Material, 2021 & 2032
Figure 79: Italy Hemostatic Gels Market Share Analysis (%), By Indication, 2021 & 2032
Figure 80: Italy Hemostatic Gels Market Share Analysis (%), By End User, 2021 & 2032
Figure 81: France Market Value Proportion Analysis, 2021
Figure 82: Global Vs France Y-o-Y Growth Comparison, 2021-2032
Figure 83: France Hemostatic Gels Market Share Analysis (%), By Material, 2021 & 2032
Figure 84: France Hemostatic Gels Market Share Analysis (%), By Indication, 2021 & 2032
Figure 85: France Hemostatic Gels Market Share Analysis (%), By End User, 2021 & 2032
Figure 86: U.K. Market Value Proportion Analysis, 2021
Figure 87: Global Vs U.K. Y-o-Y Growth Comparison, 2021-2032
Figure 88: U.K. Hemostatic Gels Market Share Analysis (%), By Material, 2021 & 2032
Figure 89: U.K. Hemostatic Gels Market Share Analysis (%), By Indication, 2021 & 2032
Figure 90: U.K. Hemostatic Gels Market Share Analysis (%), By End User, 2021 & 2032
Figure 91: Spain Market Value Proportion Analysis, 2021
Figure 92: Global Vs Spain Y-o-Y Growth Comparison, 2021-2032
Figure 93: Spain Hemostatic Gels Market Share Analysis (%), By Material, 2021 & 2032
Figure 94: Spain Hemostatic Gels Market Share Analysis (%), By Indication, 2021 & 2032
Figure 95: Spain Hemostatic Gels Market Share Analysis (%), By End User, 2021 & 2032
Figure 96: BENELUX Market Value Proportion Analysis, 2021
Figure 97: Global Vs BENELUX Y-o-Y Growth Comparison, 2021-2032
Figure 98: BENELUX Hemostatic Gels Market Share Analysis (%), By Material, 2021 & 2032
Figure 99: BENELUX Hemostatic Gels Market Share Analysis (%), By Indication, 2021 & 2032
Figure 100: BENELUX Hemostatic Gels Market Share Analysis (%), By End User, 2021 & 2032
Figure 101: Russia Market Value Proportion Analysis, 2021
Figure 102: Global Vs Russia Y-o-Y Growth Comparison, 2021-2032
Figure 103: Russia Hemostatic Gels Market Share Analysis (%), By Material, 2021 & 2032
Figure 104: Russia Hemostatic Gels Market Share Analysis (%), By Indication, 2021 & 2032
Figure 105: Russia Hemostatic Gels Market Share Analysis (%), By End User, 2021 & 2032
Figure 106: South Asia Hemostatic Gels Market Share Analysis (%), By Country (2022)
Figure 107: South Asia Hemostatic Gels Market Share Analysis (%), By Material (2022)
Figure 108: South Asia Hemostatic Gels Market Share Analysis (%), By Indication (2022)
Figure 109: South Asia Hemostatic Gels Market Share Analysis (%), By End User (2022)
Figure 110: South Asia Hemostatic Gels Market Historical Market Value (US$ Mn) Analysis, 2017–2021
Figure 111: South Asia Hemostatic Gels Market Current and Future Market Value (US$ Mn), 2022-2032 & Y-o-Y Growth Trend Analysis
Figure 112: South Asia Hemostatic Gels Market Market Attractiveness Analysis, By Country
Figure 113: South Asia Hemostatic Gels Market Attractiveness Analysis, By Material
Figure 114: South Asia Hemostatic Gels Market Market Attractiveness Analysis, By Indication
Figure 115: South Asia Hemostatic Gels Market Attractiveness Analysis, By End User
Figure 116: India Market Value Proportion Analysis, 2021
Figure 117: Global Vs India Y-o-Y Growth Comparison, 2021-2032
Figure 118: India Hemostatic Gels Market Share Analysis (%), By Material, 2021 & 2032
Figure 119: India Hemostatic Gels Market Share Analysis (%), By Indication, 2021 & 2032
Figure 120: India Hemostatic Gels Market Share Analysis (%), By End User, 2021 & 2032
Figure 121: Thailand Market Value Proportion Analysis, 2021
Figure 122: Global Vs Thailand Y-o-Y Growth Comparison, 2021-2032
Figure 123: Thailand Hemostatic Gels Market Share Analysis (%), By Material, 2021 & 2032
Figure 124: Thailand Hemostatic Gels Market Share Analysis (%), By Indication, 2021 & 2032
Figure 125: Thailand Hemostatic Gels Market Share Analysis (%), By End User, 2021 & 2032
Figure 126: Indonesia Market Value Proportion Analysis, 2021
Figure 127: Global Vs Indonesia Y-o-Y Growth Comparison, 2021-2032
Figure 128: Indonesia Hemostatic Gels Market Share Analysis (%), By Material, 2021 & 2032
Figure 129: Indonesia Hemostatic Gels Market Share Analysis (%), By Indication, 2021 & 2032
Figure 130: Indonesia Hemostatic Gels Market Share Analysis (%), By End User, 2021 & 2032
Figure 131: Malaysia Market Value Proportion Analysis, 2021
Figure 132: Global Vs Malaysia Y-o-Y Growth Comparison, 2021-2032
Figure 133: Malaysia Hemostatic Gels Market Share Analysis (%), By Material, 2021 & 2032
Figure 134: Malaysia Hemostatic Gels Market Share Analysis (%), By Indication, 2021 & 2032
Figure 135: Malaysia Hemostatic Gels Market Share Analysis (%), By End User, 2021 & 2032
Figure 136: East Asia Hemostatic Gels Market Share Analysis (%), By Country (2022)
Figure 137: East Asia Hemostatic Gels Market Share Analysis (%), By Material (2022)
Figure 138: East Asia Hemostatic Gels Market Share Analysis (%), By Indication (2022)
Figure 139: East Asia Hemostatic Gels Market Share Analysis (%), By End User (2022)
Figure 140: East Asia Hemostatic Gels Market Historical Market Value (US$ Mn) Analysis, 2017–2021
Figure 141: East Asia Hemostatic Gels Market Current and Future Market Value (US$ Mn), 2022-2032 & Y-o-Y Growth Trend Analysis
Figure 142: East Asia Hemostatic Gels Market Market Attractiveness Analysis, By Country
Figure 143: East Asia Hemostatic Gels Market Attractiveness Analysis, By Material
Figure 144: East Asia Hemostatic Gels Market Market Attractiveness Analysis, By Indication
Figure 145: East Asia Hemostatic Gels Market Attractiveness Analysis, By End User
Figure 146: China Market Value Proportion Analysis, 2021
Figure 147: Global Vs China Y-o-Y Growth Comparison, 2021-2032
Figure 148: China Hemostatic Gels Market Share Analysis (%), By Material, 2021 & 2032
Figure 149: China Hemostatic Gels Market Share Analysis (%), By Indication, 2021 & 2032
Figure 150: China Hemostatic Gels Market Share Analysis (%), By End User, 2021 & 2032
Figure 151: Japan Market Value Proportion Analysis, 2021
Figure 152: Global Vs Japan Y-o-Y Growth Comparison, 2021-2032
Figure 153: Japan Hemostatic Gels Market Share Analysis (%), By Material, 2021 & 2032
Figure 154: Japan Hemostatic Gels Market Share Analysis (%), By Indication, 2021 & 2032
Figure 155: Japan Hemostatic Gels Market Share Analysis (%), By End User, 2021 & 2032
Figure 156: South Korea Market Value Proportion Analysis, 2021
Figure 157: Global Vs South Korea Y-o-Y Growth Comparison, 2021-2032
Figure 158: South Korea Hemostatic Gels Market Share Analysis (%), By Material, 2021 & 2032
Figure 159: South Korea Hemostatic Gels Market Share Analysis (%), By Indication, 2021 & 2032
Figure 160: South Korea Hemostatic Gels Market Share Analysis (%), By End User, 2021 & 2032
Figure 161: Oceania Hemostatic Gels Market Share Analysis (%), By Country (2022)
Figure 162: Oceania Hemostatic Gels Market Share Analysis (%), By Material (2022)
Figure 163: Oceania Hemostatic Gels Market Share Analysis (%), By Indication (2022)
Figure 164: Oceania Hemostatic Gels Market Share Analysis (%), By End User (2022)
Figure 165: Oceania Hemostatic Gels Market Historical Market Value (US$ Mn) Analysis, 2017–2021
Figure 166: Oceania Hemostatic Gels Market Current and Future Market Value (US$ Mn), 2022-2032 & Y-o-Y Growth Trend Analysis
Figure 167: Oceania Hemostatic Gels Market Attractiveness Analysis, By Country
Figure 168: Oceania Hemostatic Gels Market Attractiveness Analysis, By Material
Figure 169: Oceania Hemostatic Gels Market Attractiveness Analysis, By Indication
Figure 170: Oceania Hemostatic Gels Market Attractiveness Analysis, By End User
Figure 171: Australia Market Value Proportion Analysis, 2021
Figure 172: Global Vs Australia Y-o-Y Growth Comparison, 2021-2032
Figure 173: Australia Hemostatic Gels Market Share Analysis (%), By Material, 2021 & 2032
Figure 174: Australia Hemostatic Gels Market Share Analysis (%), By Indication, 2021 & 2032
Figure 175: Australia Hemostatic Gels Market Share Analysis (%), By End User, 2021 & 2032
Figure 176: New Zealand Market Value Proportion Analysis, 2021
Figure 177: Global Vs New Zealand Y-o-Y Growth Comparison, 2021-2032
Figure 178: New Zealand Hemostatic Gels Market Share Analysis (%), By Material, 2021 & 2032
Figure 179: New Zealand Hemostatic Gels Market Share Analysis (%), By Indication, 2021 & 2032
Figure 180: New Zealand Hemostatic Gels Market Share Analysis (%), By End User, 2021 & 2032
Figure 181: Middle East and Africa (MEA) Hemostatic Gels Market Share Analysis (%), By Country (2022)
Figure 182: Middle East and Africa (MEA) Hemostatic Gels Market Share Analysis (%), By Material (2022)
Figure 183: Middle East and Africa (MEA) Hemostatic Gels Market Share Analysis (%), By Indication (2022)
Figure 184: Middle East and Africa (MEA) Hemostatic Gels Market Share Analysis (%), By End User (2022)
Figure 185: Middle East and Africa (MEA) Hemostatic Gels Market Historical Market Value (US$ Mn) Analysis, 2017–2021
Figure 186: Middle East and Africa (MEA) Hemostatic Gels Market Current and Future Market Value (US$ Mn), 2022-2032 & Y-o-Y Growth Trend Analysis
Figure 187: Middle East and Africa (MEA) Hemostatic Gels Market Attractiveness Analysis, By Country
Figure 188: Middle East and Africa (MEA) Hemostatic Gels Market Attractiveness Analysis, By Material
Figure 189: Middle East and Africa (MEA) Hemostatic Gels Market Attractiveness Analysis, By Indication
Figure 190: Middle East and Africa (MEA) Hemostatic Gels Market Attractiveness Analysis, By End User
Figure 191: GCC Countries Market Value Proportion Analysis, 2021
Figure 192: Global Vs GCC Countries Y-o-Y Growth Comparison, 2021-2032
Figure 193: GCC Countries Hemostatic Gels Market Share Analysis (%), By Material, 2021 & 2032
Figure 194: GCC Countries Hemostatic Gels Market Share Analysis (%), By Indication, 2021 & 2032
Figure 195: GCC Countries Hemostatic Gels Market Share Analysis (%), By End User, 2021 & 2032
Figure 196: Turkey Market Value Proportion Analysis, 2021
Figure 197: Global Vs Turkey Y-o-Y Growth Comparison, 2021-2032
Figure 198: Turkey Hemostatic Gels Market Share Analysis (%), By Material, 2021 & 2032
Figure 199: Turkey Hemostatic Gels Market Share Analysis (%), By Indication, 2021 & 2032
Figure 200: Turkey Hemostatic Gels Market Share Analysis (%), By End User, 2021 & 2032
Figure 201: North Africa Market Value Proportion Analysis, 2021
Figure 202: Global Vs North Africa Y-o-Y Growth Comparison, 2021-2032
Figure 203: North Africa Hemostatic Gels Market Share Analysis (%), By Material, 2021 & 2032
Figure 204: North Africa Hemostatic Gels Market Share Analysis (%), By Indication, 2021 & 2032
Figure 205: North Africa Hemostatic Gels Market Share Analysis (%), By End User, 2021 & 2032
Figure 206: South Africa Market Value Proportion Analysis, 2021
Figure 207: Global Vs South Africa Y-o-Y Growth Comparison, 2021-2032
Figure 208: South Africa Hemostatic Gels Market Share Analysis (%), By Material, 2021 & 2032
Figure 209: South Africa Hemostatic Gels Market Share Analysis (%), By Indication, 2021 & 2032
Figure 210: South Africa Hemostatic Gels Market Share Analysis (%), By End User, 2021 & 2032
The hemostatic gels market is expected to reach USD 2.17 billion by the end of 2035, with sales revenue expected to register at 6.6% CAGR.
The growing volume of surgical procedures and the increasing need for hemostatic gels in blood loss management are some of the key trends in this market.
The USA the UK, India, China, and Brazil are expected to drive demand for the hemostatic gels industry.
North America is one of the key markets for hemostatic gels, with the USA accounting for about 82% of the North American hemostatic gels market in the year 2024.
Demand for hemostatic gels in Europe is expected to register a growth of 7.1% over the next ten years.
The USA, the UK, India, and China are the key producers of hemostatic gels.
Baxter, Bio-Chem LLC, Clinician's Choice Dental Products Inc., Cresilon, Inc., Dsi Ltd., Endovision Co., Ltd, Ethicon USA, LLC, F&A Medical, Prevestdenpro, Septodont, Teleflex Incorporated, Ultradent Products Inc. All, Vladmiva And Medcura, Inc., Are Some Of The Key Players In The Hemostatic Gels Industry.
Hemostatic Gels Market
Thank you!
You will receive an email from our Business Development Manager. Please be sure to check your SPAM/JUNK folder too.
